Rabies Immune Globulin (Human)
This human-derived antiserum provides passive immunity against rabies virus post-exposure, consisting of purified IgG antibodies from vaccinated donors. Classified in HTS 3002.12.00 as antisera and blood fractions for prophylactic use. It is administered intramuscularly alongside vaccine for high-risk exposures.
Import Duty Rates by Country of Origin
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If produced via recombinant biotech methods without human blood source
Biotechnologically obtained immunological products like synthetic antibodies classify separately from blood fractions.
If for diagnostic reagents not intended for therapeutic administration
Chapter exclusions send diagnostic-only reagents to heading 3822.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Provide WHO prequalification or equivalent for expedited clearance in emergency imports
• Declare exact potency (IU/mL) on commercial invoice to match therapeutic labeling
• Comply with IATA dangerous goods rules for biological substances Category B shipping
Related Products under HTS 3002.12.00
Human Anti-D Immunoglobulin
This is a blood fraction derived from human plasma containing antibodies against the D antigen on red blood cells, used prophylactically to prevent Rh incompatibility in pregnancies. It qualifies under HTS 3002.12.00 as an antiserum and blood fraction prepared for therapeutic or prophylactic use. The product is obtained through plasma fractionation and purification processes.
Human Immunoglobulin G (IgG) Intravenous
IVIG is a pooled blood fraction from human plasma containing primarily IgG antibodies, used therapeutically for immune deficiencies and autoimmune disorders. It is classified under HTS 3002.12.00 as other blood fractions prepared for therapeutic uses via biotechnological purification. This sterile, high-purity product replaces missing antibodies in patients.
Tetanus Immune Globulin (Human)
A human blood fraction containing high-titer antibodies against tetanus toxin, used for passive immunization in wound management. Falls under HTS 3002.12.00 as antisera prepared for therapeutic and prophylactic purposes. It is sterile and lyophilized for intramuscular injection.
Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV)
CMV-IGIV is a purified immunoglobulin fraction from human plasma of donors with high CMV antibody titers, used prophylactically in transplant patients. It is classified under HTS 3002.12.00 as other blood fractions for therapeutic use. The product prevents CMV infection through passive antibody transfer.
Hepatitis B Immune Globulin (HBIG)
HBIG is a human plasma-derived blood fraction rich in antibodies to hepatitis B surface antigen, used for post-exposure prophylaxis. Under HTS 3002.12.00 as antisera for therapeutic and prophylactic applications. It provides immediate protection in high-risk scenarios like needlestick injuries.
Botulism Antitoxin (Trivalent, Equine)
This equine-derived antiserum neutralizes botulinum neurotoxins A, B, and E, used therapeutically for botulism poisoning. Classified in HTS 3002.12.00 as antisera prepared for therapeutic uses, including animal blood sources. It is purified to reduce hypersensitivity risks.